[Economic impact of etanercept and adalimumab biosimilars on hospitals scale covered by PharmAlp'Ain, a hospitals grouping of orders for health products].

Berreur, B; Guerin, F; Christophe, B; Limido, G; Paubel, P

[Economic impact of etanercept and adalimumab biosimilars on hospitals scale covered by PharmAlp'Ain, a hospitals grouping of orders for health products]. / Évaluation de l'impact économique des biosimilaires d'étanercept et d'adalimumab à l'échelle des établissements adhérents au groupement de commandes PharmAlp'Ain.

Berreur, B; Guerin, F; Christophe, B; Limido, G; Paubel, P.

Afiliação

Berreur B; Service pharmacie, centre technique et logistique, centre hospitalier Annecy-Genevois, 1, avenue de l'Hôpital, 74370 Metz-Tessy, France. Electronic address: bberreur@ch-annecygenevois.fr.
Guerin F; Service pharmacie, centre technique et logistique, centre hospitalier Annecy-Genevois, 1, avenue de l'Hôpital, 74370 Metz-Tessy, France.
Christophe B; Département de recherche d'informations médicalisées, 26, rue d'Aubigny, 69003 Lyon, France; Direction régionale du service médical Rhône-Alpes, 26, rue d'Aubigny, Lyon, France.
Limido G; Département de recherche d'informations médicalisées, 26, rue d'Aubigny, 69003 Lyon, France.
Paubel P; Service évaluations pharmaceutiques et bon usage, AGEPS, AP-HP, Paris, France; Faculté de pharmacie de Paris, institut droit et santé, Inserm UMR S 1145, université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France.

Ann Pharm Fr ; 76(1): 57-63, 2018 Jan.

Article em Fr | MEDLINE | ID: mdl-29180236

Assuntos

Adalimumab/economia; Antineoplásicos/economia; Medicamentos Biossimilares/economia; Custos de Medicamentos/estatística & dados numéricos; Etanercepte/economia; Custos Hospitalares/estatística & dados numéricos; Adalimumab/uso terapêutico; Antineoplásicos/uso terapêutico; Medicamentos Biossimilares/uso terapêutico; Redução de Custos; Etanercepte/uso terapêutico; França; Humanos; Estudos Retrospectivos

Palavras-chave

Adalimumab; Biosimilaires; Biosimilars; Costs saving; Etanercept; Économie; Étanercept

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Custos de Medicamentos / Custos Hospitalares / Medicamentos Biossimilares / Adalimumab / Etanercepte / Antineoplásicos Tipo de estudo: Guideline / Health_economic_evaluation / Observational_studies Limite: Humans País/Região como assunto: Europa Idioma: Fr Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google